Skip to main content
Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.2510
-0.0338 (-11.87%)
At close: Nov 13, 2026, 4:00 PM EST
0.2718
+0.0208 (8.29%)
After-hours: Nov 13, 2026, 7:05 PM EST

Traws Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4932161453
Market Cap Growth
-71.21%-72.02%106.05%15.90%-74.63%-38.16%
Enterprise Value
-1327-10-29-6
Last Close Price
0.251.138.8818.6416.1463.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-1.32----
Forward PE
-8.158.158.158.158.15
PS Ratio
-3.24142.7869.2959.79235.71
PB Ratio
2.27-14.36-1.021.470.481.16
P/TBV Ratio
---1.470.481.16

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-0.94118.84---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-2.976.070.68-1.95-1.37-1.19
Net Debt / EBITDA Ratio
0.230.210.861.031.983.34
Net Debt / FCF Ratio
0.300.210.721.162.382.83
Asset Turnover
-0.160.010.010.010.01
Quick Ratio
0.870.682.002.264.829.01
Current Ratio
0.930.722.162.464.899.07
Return on Equity (ROE)
-433.36%---97.22%-50.96%-61.81%
Return on Assets (ROA)
-99.40%-62.80%-65.35%-40.89%-25.87%-27.32%
Return on Capital Employed (ROCE)
-1241.70%3379.00%-185.50%-150.80%-62.70%-33.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-586.96%101.55%-516.07%-121.00%-140.35%-30.34%
FCF Yield
-436.79%-201.39%-92.33%-114.60%-120.59%-36.58%
Buyback Yield / Dilution
-138.41%-429.93%-84.94%-0.39%-24.22%-45.07%
SEC Filings: 10-K · 10-Q